Newsletters - July 1997

Newsletters - July 1997

Sabinsa has recently introduced a new form of organically bound vanadium, Bisglycinato-oxovanadium (BGOV), to its product list. BGOV is a vanadium complex with the amino acid glycine and contains 23% elemental vanadium (anhydrous basis). The choice of glycine as a carrier of vanadium has been made based on its diverse role in metabolic processes.

Vanadium belongs to the group of biologically important "transition" elements. Apart from its potential role as a building material of bones and teeth, vanadium has been shown to have a promising application as a substitute for insulin through the activation of insulin receptors. Vanadium is highly valued by body builders and athletes who claim that it increases their energy levels and endurance.

The organic forms of vanadium are recognized as being safer, more bioavailable and therapeutically more effective than the inorganic sulfate form.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.